Table 2.
Mean glomerulosclerosis score
|
|||||
---|---|---|---|---|---|
Groups | 0 | 1 | 2 | 3 | 4 |
Control | 95.9±0.5 | 4.1±0.5 | 0.0±0.0 | 0.0±0.0 | 0.0±0.0 |
ML | 99.3±0.2 | 0.6±0.2 | 0.0±0.0 | 0.0±0.0 | 0.0±0.0 |
DOX | 0.0±0.0a | 2.1±0.3 | 7.3±0.3b | 45.1±0.8b | 45.37±0.6b |
DOX-ML | 10.0±0.1a,c | 40.1±0.4b,c | 33.6±0.6b,c | 13.2±0.7b,d | 3.0±0.2d |
ML-DOX | 18.0±0.2a,c | 32.6±0.7b,c,f | 32.±0.6b,c,e | 17.37±0.7b,d | 0.0±0.0 d,f |
Significantly decreased when compared with the control group, P =0.00.
Significantly increased when compared with the control group, P =0.00.
Significantly increased when compared with the DOX group, P =0.00.
Significantly decreased when compared with the DOX group, P =0.00.
Not significant when compared with the DOX-ML group, P =0.6.
Significantly decreased when compared with the DOX-ML group, P =0.00.